Innovation and Commercialisation in the Biopharmaceutical Industry

Innovation and Commercialisation in the Biopharmaceutical Industry

Creating and Capturing Value

Bruce Rasmussen

This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the concept of the business model, which is employed to guide the case studies and empirical analysis in the book.

Chapter 3: Open Innovation and the Networked Firm

Bruce Rasmussen

Subjects: business and management, organisational innovation, economics and finance, economics of innovation, health policy and economics, environment, biotechnology, innovation and technology, biotechnology, economics of innovation, organisational innovation, technology and ict, social policy and sociology, health policy and economics


No extract available

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information